Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
   Rule 13d-1(b)
   Rule 13d-1(c)
   Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G




Comment for Type of Reporting Person:  The total reported in Rows 5 and 7 is comprised of 6,902,000 shares of Class A common stock (the "Common Stock") of Standard Nuclear, Inc. (the "Issuer") directly held by Decisive Point Group, LLC. The total reported in Rows 6 and 8 includes: (i) 5,800,000 shares of Common Stock held directly by Decisive Point - Standard Nuclear I, LLC, (ii) 2,451,678 shares of Common Stock held directly by Decisive Point - Standard Nuclear II, LLC, (iii) 2,242,330 shares of Common Stock held directly by Decisive Point - Standard Nuclear III, LLC, (iv) 505,478 shares of Common Stock held directly by Decisive Point - Standard Nuclear IV, LLC, (v) 1,275,496 shares of Common Stock held directly by Decisive Point - Standard Nuclear V, LLC, and (vi) 7,411,828 shares of Common Stock held directly by Decisive Point Ventures II Master Fund, L.P. Decisive Point Ventures Fund II GP, LLC is the manager of Decisive Point - Standard Nuclear I, LLC, Decisive Point - Standard Nuclear II, LLC, Decisive Point - Standard Nuclear III, LLC, Decisive Point - Standard Nuclear IV, LLC, Decisive Point - Standard Nuclear V, LLC and Decisive Point Ventures II Master Fund, L.P. Decisive Point Group, LLC is the parent of Decisive Point Ventures Fund II GP, LLC. Accordingly, Decisive Point Group, LLC exercises voting and investment discretion with respect to the reported securities and may be deemed the beneficial owner of the reported securities. The reported percentage is calculated based upon 149,095,234 shares of Common Stock outstanding as of July 17, 2026, as reported by the Issuer in its Prospectus ("Prospectus") filed with the Securities & Exchange Commission ("SEC") pursuant to Rule 424(b)(4) under the Securities Act of 1933, as amended (the "Securities Act"), on July 16, 2026.


SCHEDULE 13G




Comment for Type of Reporting Person:  The reported percentage is calculated based upon 149,095,234 shares of Common Stock outstanding as of July 17, 2026, as reported by the Issuer in its Prospectus filed with the SEC pursuant to Rule 424(b)(4) under the Securities Act on July 16, 2026.


SCHEDULE 13G




Comment for Type of Reporting Person:  The reported percentage is calculated based upon 149,095,234 shares of Common Stock outstanding as of July 17, 2026, as reported by the Issuer in its Prospectus filed with the SEC pursuant to Rule 424(b)(4) under the Securities Act on July 16, 2026.


SCHEDULE 13G




Comment for Type of Reporting Person:  The reported percentage is calculated based upon 149,095,234 shares of Common Stock outstanding as of July 17, 2026, as reported by the Issuer in its Prospectus filed with the SEC pursuant to Rule 424(b)(4) under the Securities Act on July 16, 2026.


SCHEDULE 13G




Comment for Type of Reporting Person:  The reported percentage is calculated based upon 149,095,234 shares of Common Stock outstanding as of July 17, 2026, as reported by the Issuer in its Prospectus filed with the SEC pursuant to Rule 424(b)(4) under the Securities Act on July 16, 2026.


SCHEDULE 13G




Comment for Type of Reporting Person:  The reported percentage is calculated based upon 149,095,234 shares of Common Stock outstanding as of July 17, 2026, as reported by the Issuer in its Prospectus filed with the SEC pursuant to Rule 424(b)(4) under the Securities Act on July 16, 2026.


SCHEDULE 13G




Comment for Type of Reporting Person:  The reported percentage is calculated based upon 149,095,234 shares of Common Stock outstanding as of July 17, 2026, as reported by the Issuer in its Prospectus filed with the SEC pursuant to Rule 424(b)(4) under the Securities Act on July 16, 2026.


SCHEDULE 13G




Comment for Type of Reporting Person:  The reported percentage is calculated based upon 149,095,234 shares of Common Stock outstanding as of July 17, 2026, as reported by the Issuer in its Prospectus filed with the SEC pursuant to Rule 424(b)(4) under the Securities Act on July 16, 2026.


SCHEDULE 13G



 
Decisive Point Group, LLC
 
Signature:/s/ Thomas Hendrix
Name/Title:By Thomas Hendrix, its Authorized Signatory
Date:07/23/2026
 
Decisive Point - Standard Nuclear I, LLC
 
Signature:/s/ Thomas Hendrix
Name/Title:By Decisive Point Ventures Fund II GP, LLC, its Manager, By Decisive Point Group, LLC, its Sole Member, By Thomas Hendrix, its Authorized Signatory
Date:07/23/2026
 
Decisive Point - Standard Nuclear II, LLC
 
Signature:/s/ Thomas Hendrix
Name/Title:By Decisive Point Ventures Fund II GP, LLC, its Manager, By Decisive Point Group, LLC, its Sole Member, By Thomas Hendrix, its Authorized Signatory
Date:07/23/2026
 
Decisive Point - Standard Nuclear III, LLC
 
Signature:/s/ Thomas Hendrix
Name/Title:By Decisive Point Ventures Fund II GP, LLC, its Manager, By Decisive Point Group, LLC, its Sole Member, By Thomas Hendrix, its Authorized Signatory
Date:07/23/2026
 
Decisive Point - Standard Nuclear IV, LLC
 
Signature:/s/ Thomas Hendrix
Name/Title:By Decisive Point Ventures Fund II GP, LLC, its Manager, By Decisive Point Group, LLC, its Sole Member, By Thomas Hendrix, its Authorized Signatory
Date:07/23/2026
 
Decisive Point - Standard Nuclear V, LLC
 
Signature:/s/ Thomas Hendrix
Name/Title:By Decisive Point Ventures Fund II GP, LLC, its Manager, By Decisive Point Group, LLC, its Sole Member, By Thomas Hendrix, its Authorized Signatory
Date:07/23/2026
 
Decisive Point Ventures II Master Fund, L.P.
 
Signature:/s/ Thomas Hendrix
Name/Title:By Decisive Point Ventures Fund II GP, LLC, its Manager, By Decisive Point Group, LLC, its Sole Member, By Thomas Hendrix, its Authorized Signatory
Date:07/23/2026
 
Decisive Point Ventures Fund II GP, LLC
 
Signature:/s/ Thomas Hendrix
Name/Title:By Decisive Point Group, LLC, its Sole Member, By Thomas Hendrix, its Authorized Signatory
Date:07/23/2026
Exhibit Information

Exhibit 99.1 Joint Filing Agreement, dated as of July 23, 2026.


ATTACHMENTS / EXHIBITS

ATTACHMENTS / EXHIBITS

EX-99.1